Your browser doesn't support javascript.
loading
Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
Kontio, Mia; Palmu, Arto A; Syrjänen, Ritva K; Lahdenkari, Mika; Ruokokoski, Esa; Davidkin, Irja; Vaarala, Outi; Melin, Merit.
Afiliación
  • Kontio M; Department of Infectious Diseases.
  • Palmu AA; Department of Health Protection, National Institute for Health and Welfare.
  • Syrjänen RK; Department of Health Protection, National Institute for Health and Welfare.
  • Lahdenkari M; Department of Health Protection, National Institute for Health and Welfare.
  • Ruokokoski E; Department of Health Protection, National Institute for Health and Welfare.
  • Davidkin I; Department of Infectious Diseases.
  • Vaarala O; Institute of Clinical Medicine, University of Helsinki, Finland.
  • Melin M; Department of Health Protection, National Institute for Health and Welfare.
J Infect Dis ; 213(12): 2005-13, 2016 06 15.
Article en En | MEDLINE | ID: mdl-26908733
BACKGROUND: Measles-mumps-rubella (MMR) vaccinations have been offered to Finnish children at 14-18 months and 6 years of age. In May 2011, the recommended age for the first vaccine dose was lowered to 12 months because of the European measles epidemic. METHODS: Fingertip capillary blood samples were collected from 3-year-old Finnish children vaccinated once with MMR vaccine at 11-19 months of age. The immunoglobulin G (IgG) antibodies to all 3 MMR antigens were measured with enzyme-linked immunosorbent assay. Neutralizing antibodies and the avidity of antibodies were measured for measles virus. RESULTS: From April through October 2013, 187 children were enrolled. Equally high proportions of the samples were seropositive for measles virus, mumps virus, or rubella virus antibodies, and there were no significant differences in the IgG antibody concentrations in children vaccinated at 11-13 months of age, compared with those vaccinated at 17-19 months of age. However, among children vaccinated at 11-13 months of age, boys had lower antibody concentrations than girls. Neutralizing measles virus antibody titers were above the threshold for protective immunity in all 78 samples analyzed. The measles virus antibody avidity indexes were high for all children. CONCLUSIONS: MMR induces similar antibody responses in 12-month-old children as compared to 18-month-old children, but in boys increasing age appears to improve the antibody responses.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Inmunoglobulina G / Vacuna contra el Sarampión-Parotiditis-Rubéola / Sarampión / Anticuerpos Antivirales / Paperas Límite: Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: J Infect Dis Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Inmunoglobulina G / Vacuna contra el Sarampión-Parotiditis-Rubéola / Sarampión / Anticuerpos Antivirales / Paperas Límite: Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: J Infect Dis Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos